{"id":1314,"date":"2021-07-21T14:18:51","date_gmt":"2021-07-21T18:18:51","guid":{"rendered":"https:\/\/secure290.inmotionhosting.com\/~a4pcor5\/?page_id=1314"},"modified":"2025-01-23T10:05:35","modified_gmt":"2025-01-23T15:05:35","slug":"state-level-advocacy","status":"publish","type":"page","link":"https:\/\/whizkid.com\/a4pc\/advocacy\/state-level-advocacy\/","title":{"rendered":"State-level Resources"},"content":{"rendered":"<figure><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter wp-image-11574 size-full\" src=\"https:\/\/whizkid.com\/a4pc\/files\/state-advocacy-header.png\" alt=\"\" width=\"1378\" height=\"414\" \/><\/figure>\n<h2>APC State-Level Advocacy<\/h2>\n<div class=\"resource\">\n<h3>State legislation comment letters<\/h3>\n<ul>\n<li><a href=\"https:\/\/whizkid.com\/a4pc\/files\/Maryland-HB1099-comments.pdf\">Maryland HB 1099<\/a><\/li>\n<li><a href=\"https:\/\/whizkid.com\/a4pc\/files\/Illinois-HB5517-comments.pdf\">Illinois HB 5517<\/a><\/li>\n<li><a href=\"https:\/\/whizkid.com\/a4pc\/files\/Mississippi-HB648-Comments.pdf\">Mississippi HB 648<\/a><\/li>\n<li><a href=\"https:\/\/whizkid.com\/a4pc\/files\/Hawaii-HB2554-Comments.pdf\">Hawaii HB 2554<\/a><\/li>\n<\/ul>\n<\/div>\n<p><!--\n\n\n\n\n\n\n\n\n\n\n\n<div class=\"resource\">\n\n\n<h3>503B Wholesaling<\/h3>\n\n\n\n\n<ul>\n\t\n\n<li>\n\n\n<p>Massachusetts (SAME AS SL SEMAGLUTIDE LETTER)<\/p>\n\n\n<\/li>\n\n\n\t\n\n<li>\n\n\n<p>Idaho<\/p>\n\n\n\n\n<ul>\n\t\n\n<li>Letter to board<\/li>\n\n\n\t\n\n<li>Comment letter  <\/li>\n\n\n<\/ul>\n\n\n<\/li>\n\n\n\t\n\n<li>\n\n\n<p>Mississippi<\/p>\n\n\n<\/li>\n\n\n\t\n\n<li>\n\n\n<p>Alabama<\/p>\n\n\n<\/li>\n\n\n<\/ul>\n\n\n<\/div>\n\n\n\n\n\n\n\n\n\n\n\n--><\/p>\n<div class=\"resource\">\n<h3>Licensing requirements<\/h3>\n<ul>\n<li><a href=\"https:\/\/whizkid.com\/a4pc\/files\/Massachusetts-Comment-Letter-Inspection-Timelines-Dec-2024.pdf\">Massachusetts licensing inspection requirements<\/a><\/li>\n<li><a href=\"https:\/\/whizkid.com\/a4pc\/files\/Illinois-nonresident-pharmacist-license-comments.pdf\">Illinois nonresident pharmacist license<\/a><\/li>\n<li><a href=\"https:\/\/whizkid.com\/a4pc\/files\/2024-06-20_MS-letter.pdf\">Mississippi physician dispensing facility permits<\/a><\/li>\n<li><a href=\"https:\/\/whizkid.com\/a4pc\/files\/2024-06-20_VA-Letter.pdf\">Virginia pharmacy technician training requirements<\/a><\/li>\n<li>California nonresident pharmacists (coming soon)<\/li>\n<\/ul>\n<\/div>\n<div class=\"resource\">\n<h3>Memos to state boards of pharmacy<\/h3>\n<ul>\n<li><a href=\"https:\/\/whizkid.com\/a4pc\/files\/peptide-memo-to-state-BOPs.pdf\">Sharing APC\u2019s statement on peptide compounding<\/a><\/li>\n<li><a href=\"https:\/\/whizkid.com\/a4pc\/files\/2024-04_APC-NCPA-BOP-Stabilty-Studies-Letter.pdf\">Lab delays for stability studies<\/a><\/li>\n<li><a href=\"https:\/\/whizkid.com\/a4pc\/files\/Best-Practices-for-Compounding-Shortage-Drugs-1.pdf\">Compounding in shortages best practices<\/a><\/li>\n<\/ul>\n<\/div>\n<div class=\"resource\">\n<h3>GLP-1s<\/h3>\n<ul>\n<li><a href=\"https:\/\/files.constantcontact.com\/a9a22253501\/9cc0b49f-1a10-40db-b698-721a7fa94598.pdf?rdr=true\">Massachusetts sublingual semaglutide<\/a><\/li>\n<li><a href=\"https:\/\/whizkid.com\/a4pc\/files\/APC-Letter-to-MS-Medical-Board.pdf\">Mississippi medical board requesting reinstatment of waiver for off label prescribing of GLP-1s<\/a><\/li>\n<li><a href=\"https:\/\/whizkid.com\/a4pc\/files\/2024-06-20_NC-Letter.pdf\">North Carolina sublingual semaglutide<\/a><\/li>\n<li><a href=\"https:\/\/whizkid.com\/a4pc\/files\/2024-06-20_NJ-Letter.pdf\">New Jersey sublingual semaglutide<\/a><\/li>\n<\/ul>\n<\/div>\n<div class=\"resource\">\n<h3>USP<\/h3>\n<ul>\n<li><a href=\"https:\/\/whizkid.com\/a4pc\/files\/2024-12-09_California-Comments.pdf\">California USP+ compounding requirements (Part 2) (12\/09\/24)<\/a><\/li>\n<li><a href=\"https:\/\/whizkid.com\/a4pc\/files\/APC-Letter-to-NM-July-24.pdf?utm_source=hs_email&amp;utm_medium=email\">New Mexico aligning on USP and flavoring<\/a><\/li>\n<li><a href=\"https:\/\/whizkid.com\/a4pc\/files\/Texas-Sterile-Compounding-Comments-FINAL-10-29-20241.pdf\">Texas sterile compounding rules<\/a><\/li>\n<\/ul>\n<\/div>\n<div class=\"resource\">\n<h3>503B Sourcing to 503A<\/h3>\n<ul>\n<li><a href=\"https:\/\/whizkid.com\/a4pc\/files\/AL-BOP-Letter1.pdf\">Alabama<\/a><\/li>\n<li><a href=\"https:\/\/whizkid.com\/a4pc\/files\/APC-Idaho-thank-you.pdf\">APC to Idaho Board of Pharmacy<\/a><\/li>\n<li><a href=\"https:\/\/whizkid.com\/a4pc\/files\/Comments-Idaho-BOP-Proposed-Regulations1.pdf\">Idaho comments on proposed rules<\/a><\/li>\n<li><a href=\"https:\/\/files.constantcontact.com\/a9a22253501\/9cc0b49f-1a10-40db-b698-721a7fa94598.pdf?rdr=true\">Massachusetts<\/a><\/li>\n<li><a href=\"https:\/\/whizkid.com\/a4pc\/files\/MS-BOP-Letter-1.pdf\">Mississippi<\/a><\/li>\n<\/ul>\n<\/div>\n<div class=\"resource\">\n<h3>Other<\/h3>\n<ul>\n<li><a href=\"https:\/\/whizkid.com\/a4pc\/files\/APC-letter-to-ALBME.pdf\">Alabama letter about physician compounding<\/a><\/li>\n<li><a href=\"https:\/\/whizkid.com\/a4pc\/files\/MD-APC-comments-on-prescription-labeling.pdf\">Maryland prescription labeling requirements<\/a><\/li>\n<\/ul>\n<\/div>\n<hr \/>\n<h2>State-level compounding resources<\/h2>\n<h3>APC has three members-only resources covering state-level compounding issues<\/h3>\n<p><strong>Because these are restricted to APC members, you&#8217;ll need your APC log-in and password to access them.<\/strong><\/p>\n<div class=\"resource\">\n<h3 class=\"red\">Members only<\/h3>\n<ul>\n<li>State Compounding Legislation and Regulation Tracker<\/li>\n<li>Compilation of State-Adopted USP 795, 797, and 800 Rules<\/li>\n<li>Compounding for Office Use and Veterinary Office Use<\/li>\n<\/ul>\n<p><em>Created in collaboration with the National Alliance of State Pharmacy Associations and funded by a generous grant from the Pharmacy Compounding Foundation.<\/em><\/p>\n<h4 style=\"text-align: center;\"><strong><a href=\"https:\/\/members.whizkid.com\/a4pc\/stateside\/\">MEMBERS: Click here to log in <br \/>\nand access any of these resources<\/a>.<\/strong><\/h4>\n<\/div>\n<h3>Other resources<\/h3>\n<div class=\"resource\">\n<h4>Dietary supplement taxation<\/h4>\n<p><a href=\"https:\/\/blog.taxjar.com\/sales-tax-by-states-are-dietary-supplements-taxable\/\"><strong>TaxJar\u2019s listing of states<\/strong> where dietary supplements are tax exempt or taxed at a lower rate<\/a><\/p>\n<\/div>\n<div class=\"resource\">\n<h4>State-by-state e-prescribing trackers<\/h4>\n<p>Here are two organizations&#8217; tracking resources on state laws and regulation on e-prescribing. <em>Both give the same info, just the interfaces are different.<\/em><\/p>\n<ul>\n<li>From Surescripts: <strong><a href=\"https:\/\/surescripts.com\/enhance-prescribing\/e-prescribing\/e-prescribing-for-controlled-substances\/\" target=\"_blank\" rel=\"noopener\">EPCS Readiness: Which States Lead the Charge?<\/a><\/strong><\/li>\n<li>From MD Toolbox: <strong><a href=\"https:\/\/mdtoolbox.com\/eprescribe-map.aspx\" target=\"_blank\" rel=\"noopener\">E-Prescribing Mandate State Laws<\/a><\/strong><\/li>\n<\/ul>\n<figure class=\"center\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-medium wp-image-558\" src=\"https:\/\/whizkid.com\/a4pc\/files\/ecpschart-1-300x210.jpg\" alt=\"\" width=\"300\" height=\"210\" \/><\/figure>\n<\/div>\n<div class=\"graybox\" style=\"margin-top: 2rem;\">\n<h3>APC&#8217;s Stateside Coalition<\/h3>\n<p>Join our coalition of compounders who&#8217;ve volunteered to be APC&#8217;s eyes and ears and voice at their state&#8217;s board of pharmacy meetings. We&#8217;re working to have coverage in all 50 states, with at least three volunteers in each state to share the duties and assure consistent coverage of meetings.<\/p>\n<p>When we know what&#8217;s going on in your state, we can prepare you with information and talking points to effectively represent your profession.<\/p>\n<p>Interested? Contact us at <a href=\"mailto:info@whizkid.com\/a4pc\"><a href=\"mailto:info@whizkid.com\">info@whizkid.com<\/a>\/a4pc<\/a>.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>APC State-Level Advocacy State legislation comment letters Maryland HB 1099 Illinois HB 5517 Mississippi HB 648 Hawaii HB 2554 Licensing requirements Massachusetts licensing inspection requirements Illinois nonresident pharmacist license Mississippi physician dispensing facility permits Virginia pharmacy technician training requirements California nonresident pharmacists (coming soon) Memos to state boards of pharmacy Sharing APC\u2019s statement on peptide [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":30,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1314","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/whizkid.com\/a4pc\/wp-json\/wp\/v2\/pages\/1314","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/whizkid.com\/a4pc\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/whizkid.com\/a4pc\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/whizkid.com\/a4pc\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/whizkid.com\/a4pc\/wp-json\/wp\/v2\/comments?post=1314"}],"version-history":[{"count":54,"href":"https:\/\/whizkid.com\/a4pc\/wp-json\/wp\/v2\/pages\/1314\/revisions"}],"predecessor-version":[{"id":11798,"href":"https:\/\/whizkid.com\/a4pc\/wp-json\/wp\/v2\/pages\/1314\/revisions\/11798"}],"up":[{"embeddable":true,"href":"https:\/\/whizkid.com\/a4pc\/wp-json\/wp\/v2\/pages\/30"}],"wp:attachment":[{"href":"https:\/\/whizkid.com\/a4pc\/wp-json\/wp\/v2\/media?parent=1314"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}